CoapTech Competitors and Similar CompaniesClear all
Evergen's competitors and similar companies include Alcresta and Eyenovia.
 Evergen Evergen (formerly known as RTI Surgical) is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. |  Alcresta Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. |  Eyenovia Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform. | |
Founding Date | Founding Date 1998 | Founding Date 2011 | Founding Date 2014 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Alachua, US HQ Metz, FR Neunkirchen Am Brand, DE Houten, NL Singapore, SG Greenville, US Marquette, US see more | Locations Newton, US HQ | Locations New York, US HQ |
Employees | Employees 8915% decrease | Employees 82 | Employees 22100% increase |
Financial | |||
Revenue (est.) | Revenue (est.) $280.9m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $813.5k (FY, 2025) |
Cost of goods | Cost of goods $140.7m (FY, 2018) | Cost of goods N/A | Cost of goods $303.3k (FY, 2025) |
Gross profit | Gross profit $140.1m (FY, 2018) | Gross profit N/A | Gross profit $510.2k (FY, 2025) |
Net income | Net income ($1.3m) (FY, 2018) | Net income N/A | Net income ($45.3m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Alcresta
HQ
Newton, US
Employees
82
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
View companyEyenovia
HQ
New York, US
Employees
22
Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform.
View company